Medtronic Hopes To Refine Renal Denervation Hypertension Therapy With New Trial

The 50-patient SPYRAL DYSTAL trial will evaluate the benefits of a new targeted renal denervation approach with the Symplicity Spyral renal denervation system in patients with uncontrolled hypertension.

Blood pressure measuring. Doctor and patient. Health care.
• Source: shutterstock.com

Medtronic PLC is advancing renal denervation therapy for hypertension with a new trial evaluating a simplified approach for radiofrequency ablation of the renal nerves.

Renal denervation is the ablation of the renal nerves to interrupt renal sympathetic nerve activity that contributes to hypertension

More from Clinical Trials

More from R&D